More Than A Meal
Entyce® (capromorelin oral solution) supports dogs facing long-term health challenges by addressing inappetence, which is essential for improving nutrition.¹
Entyce® (capromorelin oral solution)
Entyce is the only FDA-approved veterinary therapeutic for appetite stimulation in dogs. Entyce works naturally as a ghrelin receptor agonist to trigger feelings of hunger, which increases appetite, leading to increased food consumption.
Stamina starts with appetite.
Prescribe Entyce with Confidence
Entyce delivers visible results with ~7/10 dog owners reporting increased appetite in just 4 days of treatment, compared to 4.5/10 control dogs.3
Dogs with long-term health conditions can safely take Entyce throughout their treatment journey, even with a wide range of comorbidities.*
Entyce works like the body’s own natural hunger hormone, ghrelin.
Entyce increases appetite, leading to increased food consumption.
Entyce works like the body’s own natural hunger hormone, ghrelin
Entyce mimics ghrelin, triggering them to eat, which helps increase food consumption.
Consider Entyce as an essential part of your treatment plan
In the field study, 171 inappetent dogs were assessed for safety over 4 days3
- Dogs had a wide range of medical conditions.3
- Entyce was generally well tolerated.
The most commonly observed adverse events included diarrhea, vomiting, elevated blood urea nitrogen, polydipsia, and hypersalivation.
Toxicity was assessed for 12 consecutive months of treatment in healthy dogs, supporting safety at the labeled dose.4
- Findings included increased salivation, reddening/swollen paws, increased liver weights, and hepatocellular cytoplasmic vacuolation
Entyce is safe to use daily, leading to changes pet owners can see
After 4 days of treatment with Entyce, pet owners reported increased:3
- Willingness to eat
- Anticipation of mealtime
- Hunger behavior
- Enthusiasm for food
Choose Entyce for dogs with long-term conditions – because stamina starts with appetite
*The effectiveness of Entyce has not been studied beyond 4 days in the clinical study. Use with caution in dogs with hepatic dysfunction or renal insufficiency.
INDICATION: For appetite stimulation in dogs.
IMPORTANT SAFETY INFORMATION: For use in dogs only. Do not use in dogs that have a hypersensitivity to capromorelin. Use with caution in dogs with hepatic dysfunction or renal insufficiency. The safe use of Entyce has not been evaluated in breeding, pregnant or lactating dogs. The most common adverse reactions included diarrhea, vomiting, elevated blood urea nitrogen, polydipsia, and hypersalivation.
Please see Entyce product label for full Prescribing Information.